Abstract:Background: Metastasis is a major cause of death in UM, highlighting the need to use highly specific and sensitive prognostic markers to identify patients with a risk of developing metastasis. Aims: The aim of this study was to improve the current precision treatment for patients with metastatic uveal melanoma (UM). Objective: The objective of this work was to investigate the heterogeneity between primary human UM and metastatic UM at the single-cell level and to discover potential molecules regulating UM metastasis. Methods: Seurat R toolkit was employed to analyze single-cell sequencing data of UM and to identify differentially expressed genes (DEGs) between primary and metastatic UM. Least absolute shrinkage and selection operator (LASSO) and Cox regression analyses were performed on the DEGs from the bulk RNA-seq cohort to develop a prognostic model. Based on the model, patients were divided into high and low groups. The correlations among the risk score, immune indicators, immune checkpoint blockade (ICB) therapy, and anti-tumor drug therapy were analyzed. result: Cell types in primary UM and metastatic UM tumors include B/plasma cells, endothelial cells, melanocyte, monocytes/macrophages, The photoreceptor cells and T cells. There were 157 DEGs between the two tumor types, among which S100A4, PDE4B, CHCHD10, NSG1 and C4orf48 were picked out to construct the metastasis model. The metastasis model could accurately and independently predict the risk of death and metastasis in UM, and also showed predictive usefulness for immune infiltration, response to ICB treatment, and sensitivity to antineoplastic drugs. Results: Cell types in primary UM and metastatic UM tumors include B/plasma cells, endothelial cells, melanocytes, monocytes/macrophages, photoreceptor cells, and T cells. Among 157 DEGs between the two tumor types, S100A4, PDE4B, CHCHD10, NSG1, and C4orf48 were selected to construct a prognostic model. The model could accurately and independently predict response to ICB treatment and sensitivity to antineoplastic drugs for UM patients as well as their immune infiltration levels, risk of death, and metastasis possibility. Conclusions: This study analyzed the tumor ecosystem of primary and metastatic UM, providing a metastasis-related model that could be used to evaluate the prognosis, risk of metastasis, immunotherapy, and efficacy of antineoplastic drug treatment of UM.

Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis

The Prognostic Landscape of Adaptive Immune Resistance Signatures and Infiltrating Immune Cells in the Tumor Microenvironment of Uveal Melanoma.

Identification of Prognostic Signatures for Predicting the Overall Survival of Uveal Melanoma Patients

Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data

Prognostic Prediction and Immune Microenvironment Characterization in Uveal Melanoma: A Novel Mitochondrial Metabolism-Related Gene Signature

Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma

A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma

Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma

Identification of survival-related metabolic genes and a novel gene signature predicting the overall survival for patients with uveal melanoma

Immune classification and identification of prognostic genes for uveal melanoma based on six immune cell signatures

Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma

The prognostic value of immune-related genes AZGP1, SLCO5A1, and CTF1 in Uveal melanoma

Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients

Integrated Analysis of Genes Associated With Immune Microenvironment and Distant Metastasis in Uveal Melanoma

Validation of an Ultraviolet Light Response Gene Signature for Predicting Prognosis in Patients with Uveal Melanoma

Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma

Integrated single-cell and transcriptome sequencing analyses develops a metastasis-based risk score system for prognosis and immunotherapy response in uveal melanoma

Integrating Single-cell and Bulk RNA-seq to Construct a Metastasis-related Model for Evaluating Immunotherapy and Chemotherapy in Uveal Melanoma

A Novel Four Genes of Prognostic Signature for Uveal Melanoma